Hospital News
Return to Angioplasty and Stenting Overview
More on Angioplasty and Stenting
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- 9/11 Lifestyle Changes May Increase Cardiovascular Risk
- Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- A NYC First: Patient Participates in Stem Cell Clinical Trial to Repair Heart Damaged by Severe Coronary Artery Disease
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- Columbia University Medical Center Study Shows Stress Test Saves Lives of Patients With Chest Pain
- Computerized Electrocardiogram Rhythm Errors Common, NewYork-Presbyterian/Weill Cornell Study Finds
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Do Heart Disease and Cancer Have a Common Genetic Link?
- For High-Blood-Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Heart Failure
- Gene Test Detects Heart Transplant Rejection
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Heart Health Inspiration & Strategies for the Whole Family
- JAMA Article Looks at Data-Sharing in Clinical Trials for Heart Disease
- Keeping the Beat: NewYork-Presbyterian Offers Heart Patients New Combination Defibrillator/Pacemakers
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- Lupus Patients at Increased Risk for Atherosclerosis, Weill Cornell Study Finds
- New Intravascular Radiation Procedures Reduce Renarrowing of Coronary Arteries
- New Laser Technology Offers Promise for Heart Disease Patients
- New Methodology Gives Weill Cornell Team Insights into Psychological Value of Cardiac Stress Testing
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Findings at American Heart Association's Annual Conference
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American College of Cardiology's 57th Annual Scientific Session
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physician-Scientists Present Clinical Research at American Heart Association's Annual Conference
- Physician-Scientist Urges Improved Drug Regulation to Ensure Safety of Non-Heart Drugs
- Potential for Adult Stem Cells to Repair Hearts Damaged by Severe Coronary Artery Disease Investigated in Ongoing Study
- Reducing Enlarged Heart Muscle Cuts Patients' Cardiac Risk, Independent of Lowered Blood Pressure, NewYork-Presbyterian/Weill Cornell Researchers Report
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Weill Cornell Receives $7.6 Million Federal Grant for Clinical Trials on New Ways To Change Behavior in Patients With Cardiopulmonary Disease
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
- Weill Cornell Scientists Reveal Action of a Histamine Receptor That May Lead to New Therapies for Heart Attacks
Research and Clinical Trials
Return to Angioplasty and Stenting Overview
More on Angioplasty and Stenting
Health Library
Clinical Services
Return to Angioplasty and Stenting Overview
More on Angioplasty and Stenting
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Arrhythmia Control
- Artificial Heart Devices: LVAD
- Cardiac Electrophysiologic Studies and T-wave Alternans Testing
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Transplant Surgery
- Heart Valve Repair and Replacement
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- Tilt Testing
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
- Treatments for Heart Valve Disease
Angioplasty and Stenting
Angioplasty
Angioplasty is used to re-open coronary arteries that have become narrowed by atherosclerotic plaques. This procedure is used to treat blocked coronary arteries as well as arteries in other parts of the body. Angioplasty requires only local anesthesia and perhaps mild sedation (relaxing medications). Patients typically spend the night in the hospital and are able to return to normal activity in a day or two.
During balloon angioplasty, a thin tube (catheter) is inserted into an artery in the groin. A tiny balloon is then passed through the catheter and is guided to the narrowed area(s), where the balloon is expanded to stretch open the artery.
In many cases, angioplasty is followed by the insertion of a stent – a metallic tubular mesh that acts as a scaffold, holding the artery open. At NewYork-Presbyterian Hospital, we offer the latest stenting technology, including drug-coated stents that help to prevent the blockage from re-forming at a later time.
Stenting
A coronary stent is a tubular metal mesh that is used to keep coronary arteries open. Since the stent will be placed inside an artery, the device comes in various sizes to match the size of the artery. The stent, which is mounted on a small balloon, is guided to a coronary artery, and is expanded by inflating the balloon. The stent is left permanently in the artery. NewYork-Presbyterian Hospital uses the latest in stent technology, including drug-coated stents whenever and wherever possible to maintain a very low risk of recurrent narrowing of the artery.
NewYork-Presbyterian is in the vanguard of development of new stents. In addition, upcoming studies will investigate the efficacy of the second generation of drug-coated stents.
Find a Physician
Hospital News
Clinical Services
RELATED LINKS
- Cardiology, NewYork-Presbyterian/Columbia
- Cardiology, NewYork-Presbyterian/Weill Cornell
- NewYork-Presbyterian Heart
- NewYork-Presbyterian Heart Advanced Diagnostics
- Cardiology Research, NewYork-Presbyterian/Columbia
- Cardiolovascular Research, NewYork-Presbyterian/Columbia
- Cardiology Research, NewYork-Presbyterian/Weill Cornell
